The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biopharma Outsourcing Market Research Report 2024
Synopsis
Biopharma outsourcing plays an important role in the growth of biopharmaceuticals market. The growth of this market is promising with rapidly expanding biosimilars base.
The global Biopharma Outsourcing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biopharma Outsourcing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharma Outsourcing.
Report Scope
The Biopharma Outsourcing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharma Outsourcing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharma Outsourcing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sartorius
Emcure Pharmaceuticals
BioPharma Services
Lambda Therapeutic Research
Baxter Healthcare
Keyrus Biopharma
Quintiles
Aptuit
KBI Biopharm
ICON
Segment by Type
Raw Material Sourcing
Active Pharmaceutical Ingredient
Finished Drugs
Segment by Application
Drug Discovery
Clinical Trials
Preclinical Development
Biology Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharma Outsourcing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Biopharma outsourcing plays an important role in the growth of biopharmaceuticals market. The growth of this market is promising with rapidly expanding biosimilars base.
The global Biopharma Outsourcing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biopharma Outsourcing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharma Outsourcing.
Report Scope
The Biopharma Outsourcing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharma Outsourcing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharma Outsourcing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sartorius
Emcure Pharmaceuticals
BioPharma Services
Lambda Therapeutic Research
Baxter Healthcare
Keyrus Biopharma
Quintiles
Aptuit
KBI Biopharm
ICON
Segment by Type
Raw Material Sourcing
Active Pharmaceutical Ingredient
Finished Drugs
Segment by Application
Drug Discovery
Clinical Trials
Preclinical Development
Biology Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharma Outsourcing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharma Outsourcing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Raw Material Sourcing
1.2.3 Active Pharmaceutical Ingredient
1.2.4 Finished Drugs
1.3 Market by Application
1.3.1 Global Biopharma Outsourcing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery
1.3.3 Clinical Trials
1.3.4 Preclinical Development
1.3.5 Biology Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharma Outsourcing Market Perspective (2019-2030)
2.2 Biopharma Outsourcing Growth Trends by Region
2.2.1 Global Biopharma Outsourcing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biopharma Outsourcing Historic Market Size by Region (2019-2024)
2.2.3 Biopharma Outsourcing Forecasted Market Size by Region (2025-2030)
2.3 Biopharma Outsourcing Market Dynamics
2.3.1 Biopharma Outsourcing Industry Trends
2.3.2 Biopharma Outsourcing Market Drivers
2.3.3 Biopharma Outsourcing Market Challenges
2.3.4 Biopharma Outsourcing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharma Outsourcing Players by Revenue
3.1.1 Global Top Biopharma Outsourcing Players by Revenue (2019-2024)
3.1.2 Global Biopharma Outsourcing Revenue Market Share by Players (2019-2024)
3.2 Global Biopharma Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharma Outsourcing Revenue
3.4 Global Biopharma Outsourcing Market Concentration Ratio
3.4.1 Global Biopharma Outsourcing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharma Outsourcing Revenue in 2023
3.5 Biopharma Outsourcing Key Players Head office and Area Served
3.6 Key Players Biopharma Outsourcing Product Solution and Service
3.7 Date of Enter into Biopharma Outsourcing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharma Outsourcing Breakdown Data by Type
4.1 Global Biopharma Outsourcing Historic Market Size by Type (2019-2024)
4.2 Global Biopharma Outsourcing Forecasted Market Size by Type (2025-2030)
5 Biopharma Outsourcing Breakdown Data by Application
5.1 Global Biopharma Outsourcing Historic Market Size by Application (2019-2024)
5.2 Global Biopharma Outsourcing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biopharma Outsourcing Market Size (2019-2030)
6.2 North America Biopharma Outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biopharma Outsourcing Market Size by Country (2019-2024)
6.4 North America Biopharma Outsourcing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharma Outsourcing Market Size (2019-2030)
7.2 Europe Biopharma Outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biopharma Outsourcing Market Size by Country (2019-2024)
7.4 Europe Biopharma Outsourcing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharma Outsourcing Market Size (2019-2030)
8.2 Asia-Pacific Biopharma Outsourcing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biopharma Outsourcing Market Size by Region (2019-2024)
8.4 Asia-Pacific Biopharma Outsourcing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharma Outsourcing Market Size (2019-2030)
9.2 Latin America Biopharma Outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biopharma Outsourcing Market Size by Country (2019-2024)
9.4 Latin America Biopharma Outsourcing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharma Outsourcing Market Size (2019-2030)
10.2 Middle East & Africa Biopharma Outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biopharma Outsourcing Market Size by Country (2019-2024)
10.4 Middle East & Africa Biopharma Outsourcing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sartorius
11.1.1 Sartorius Company Detail
11.1.2 Sartorius Business Overview
11.1.3 Sartorius Biopharma Outsourcing Introduction
11.1.4 Sartorius Revenue in Biopharma Outsourcing Business (2019-2024)
11.1.5 Sartorius Recent Development
11.2 Emcure Pharmaceuticals
11.2.1 Emcure Pharmaceuticals Company Detail
11.2.2 Emcure Pharmaceuticals Business Overview
11.2.3 Emcure Pharmaceuticals Biopharma Outsourcing Introduction
11.2.4 Emcure Pharmaceuticals Revenue in Biopharma Outsourcing Business (2019-2024)
11.2.5 Emcure Pharmaceuticals Recent Development
11.3 BioPharma Services
11.3.1 BioPharma Services Company Detail
11.3.2 BioPharma Services Business Overview
11.3.3 BioPharma Services Biopharma Outsourcing Introduction
11.3.4 BioPharma Services Revenue in Biopharma Outsourcing Business (2019-2024)
11.3.5 BioPharma Services Recent Development
11.4 Lambda Therapeutic Research
11.4.1 Lambda Therapeutic Research Company Detail
11.4.2 Lambda Therapeutic Research Business Overview
11.4.3 Lambda Therapeutic Research Biopharma Outsourcing Introduction
11.4.4 Lambda Therapeutic Research Revenue in Biopharma Outsourcing Business (2019-2024)
11.4.5 Lambda Therapeutic Research Recent Development
11.5 Baxter Healthcare
11.5.1 Baxter Healthcare Company Detail
11.5.2 Baxter Healthcare Business Overview
11.5.3 Baxter Healthcare Biopharma Outsourcing Introduction
11.5.4 Baxter Healthcare Revenue in Biopharma Outsourcing Business (2019-2024)
11.5.5 Baxter Healthcare Recent Development
11.6 Keyrus Biopharma
11.6.1 Keyrus Biopharma Company Detail
11.6.2 Keyrus Biopharma Business Overview
11.6.3 Keyrus Biopharma Biopharma Outsourcing Introduction
11.6.4 Keyrus Biopharma Revenue in Biopharma Outsourcing Business (2019-2024)
11.6.5 Keyrus Biopharma Recent Development
11.7 Quintiles
11.7.1 Quintiles Company Detail
11.7.2 Quintiles Business Overview
11.7.3 Quintiles Biopharma Outsourcing Introduction
11.7.4 Quintiles Revenue in Biopharma Outsourcing Business (2019-2024)
11.7.5 Quintiles Recent Development
11.8 Aptuit
11.8.1 Aptuit Company Detail
11.8.2 Aptuit Business Overview
11.8.3 Aptuit Biopharma Outsourcing Introduction
11.8.4 Aptuit Revenue in Biopharma Outsourcing Business (2019-2024)
11.8.5 Aptuit Recent Development
11.9 KBI Biopharm
11.9.1 KBI Biopharm Company Detail
11.9.2 KBI Biopharm Business Overview
11.9.3 KBI Biopharm Biopharma Outsourcing Introduction
11.9.4 KBI Biopharm Revenue in Biopharma Outsourcing Business (2019-2024)
11.9.5 KBI Biopharm Recent Development
11.10 ICON
11.10.1 ICON Company Detail
11.10.2 ICON Business Overview
11.10.3 ICON Biopharma Outsourcing Introduction
11.10.4 ICON Revenue in Biopharma Outsourcing Business (2019-2024)
11.10.5 ICON Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
